Cora M. Pierce

Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration

I. Constable, E. Rakoczy, M. Blumenkranz, 2016, EBioMedicine.

Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial

Ian J Constable, Steven D Schwartz, I. Constable, 2015, The Lancet.

Three-year follow-up of Phase 1 and 2a rAAV.sFLT-1 subretinal gene therapy trials for exudative age related macular degeneration.

I J Constable, I. Constable, E. Rakoczy, 2019, American journal of ophthalmology.